Since his second term started, President Trump has introduced a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry.

Minnesota's Legislature is reckoning with 340B, a prescription medication discount program for nonprofit hospitals, for ...

Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...

The powerful synthetic opioid cychlorphine, first flagged by a DEA lab in 2024, has since been observed in cases across at ...

With President Donald Trump recently signing an executive order to accelerate research and ease the restrictions on ...

Donovan: Pfizer CentreOne’s oral solid dose network is built around three strategically positioned manufacturing sites: ...

Peptide therapeutics require tailored ADME strategies to address stability, supporting more effective and reliable drug ...

Identity is difficult to define for a single person—much less an entire organization. But like Nike’s “Just Do it” and Subway ...

Bright Uro, a medical device company with a mission to transform care for lower urinary tract dysfunction (LUTD) through ...

When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...

In addition to the briefs from the parties, seventeen amicus briefs were filed with the Supreme Court in Hikma v. Amarin: six in favor of ...

Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA Breakthrough Therapy and EMA PRIME ...